Article info

PDF

DGI-020 Cost and Effectiveness of Targeted Treatment with Cetuximab or Bevacizumab as Maintenance Treatment in Patients with Colorectal Cancer

Authors

Citation

Rizza G, Bellavia G, Scorsone C, et al
DGI-020 Cost and Effectiveness of Targeted Treatment with Cetuximab or Bevacizumab as Maintenance Treatment in Patients with Colorectal Cancer

Publication history

  • First published March 12, 2013.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.